Curative Financial Statements From 2010 to 2026
| CUBT Stock | USD 0.01 0.0004 5.56% |
Check Curative Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curative Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Curative financial statements analysis is a perfect complement when working with Curative Biotechnology Valuation or Volatility modules.
Check out the analysis of Curative Biotechnology Correlation against competitors. Curative Biotechnology Company Shares Outstanding Analysis
Curative Biotechnology's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Curative Biotechnology Shares Outstanding | 1.05 B |
Most of Curative Biotechnology's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curative Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Curative Biotechnology has 1.05 B of shares currently outstending. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 82.94% lower than that of the firm.
Curative Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Curative Biotechnology's current stock value. Our valuation model uses many indicators to compare Curative Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Curative Biotechnology competition to find correlations between indicators driving Curative Biotechnology's intrinsic value. More Info.Curative Biotechnology is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Curative Biotechnology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Curative Biotechnology Financial Statements
Curative Biotechnology shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Curative Biotechnology investors may analyze each financial statement separately, they are all interrelated. The changes in Curative Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Curative Biotechnology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.